Dynavax Technologies Corporation (DVAX)

Dynavax Technologies Corporation (DVAX $15.38)
- $15.38 Cap: $1.80B
- View DVAX Profile
- View Questions on DVAX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Dynavax Technologies Corporation (DVAX $15.38)
- $15.38 Cap: $1.80B
- View DVAX Profile
- View Questions on DVAX

Q: May I have your comments on DVAX? They seem to have strong earnings but is their outlook for 2026 negative? Please also comment on their cash flow, debt, dividend sustainability, share buyback, insider ownership and another aspects you feel are noteworthy. The stock charts red because it has declined 16% YTD. I do not own the stock. The stock seems to be too small to be a value trap but I am a little puzzled why it can’t seem to gain traction.
Thank you,
Jim

Read Answer Asked by James on December 16, 2025

Merck & Company Inc. (MRK $106.45)
- $106.45 P/E (TTM): 13.88X Cap: $264.21B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $25.03)
- $25.03 P/E (TTM): 14.66X Cap: $142.31B
- View PFE Profile
- View Questions on PFE
GSK plc American Depositary Shares (Each representing two) (GSK $48.96)
- $48.96 P/E (TTM): 29.27X Cap: $99.43B
- View GSK Profile
- View Questions on GSK
Dynavax Technologies Corporation (DVAX $15.38)
- $15.38 Cap: $1.80B
- View DVAX Profile
- View Questions on DVAX

Q: I understand there has been some type of study which shows people who have taken the Shingles vaccine are less likely to develop Alzheimer’s like diseases. The scientific community seems not to know why this is so. There are a lot of unknowns on this study to say the least. Do you know any first rate Pharma companies that are leaders in the development and manufacturing the Shingles vaccines? I know there are a number of Shingles vaccines out in the marketplace, probably made by different companies. Does Bloomberg have anything to say on the subject? Any thoughts you have would be appreciated.
Jim

Read Answer Asked by James on December 04, 2025